|
Communiqués
SMALL BONE INNOVATIONS,
INC. RECEIVES US FDA 510(k) CLEARANCE FOR MINI-RAIL FIXATION
SYSTEM AND LARGE CANNULATED SCREW SYSTEM
- Supports and enhances expansion of
lower limb continuum of care product portfolio
- Innovative instrumentation and versatility
may reduce OR time
NEW YORK, NY:
February 24, 2010 -
Small Bone Innovations, Inc. (SBi), a leading, privately-held
orthopedics company focused exclusively on technologies and
treatments for the small bones & joints, announced that
it has received 510(k) pre-market clearance notifications
from the U.S. Food and Drug Administration (FDA) for Mini-Rail
Fixation System (‘Mini-Rail System’) and large
Cannulated Screw System for use in lower limb reconstruction
and repair procedures.
The Mini-Rail and Cannulated Screw systems further expand
SBi’s lower limb continuum of care product line.
SBi expects its Mini-Rail System to be used in common procedures
such as first MTP (metatarsophalangeal) joint arthrodesis
and distraction, subtalar fusion, and Jones fracture management.
There are approximately 65,000 of these procedures performed
annually in the U.S.*
The Mini-Rail System is a unique and highly adjustable fixation
system that lets surgeons quickly achieve optimal placement
in the bones of fixation “half” pins. The system’s
ease of use can decrease OR time. The Mini-Rail System was
launched following a series of extensive evaluations by U.S.
foot and ankle surgeons.
Guido LaPorta, DPM, FACFAS, Chief of Foot and Ankle Surgery
at Community Medical Center, Scranton PA., said: "The
SBi Mini-Rail System offers a versatile solution for small
bone reconstruction and trauma. The system’s design
allows it to be used as primary or complementary fixation
in arthrodesis, osteotomy, bone lengthening and fracture repair.
The system’s unique instrumentation allows us to employ
the Mini-Rail System as an anatomically accurate and rigid
construct.”
SBi expects the large Cannulated Screw System, made out of
stainless steel, to be used for a variety of foot and ankle
procedures including triple arthrodesis, subtalar and ankle
fusions. There are approximately 50,000 of these procedures
performed annually in the U.S.*
Anthony G. Viscogliosi, Chairman & CEO of SBi, said: “Both
the Mini-Rail and large Cannulated Screw systems have been
designed specifically for use in a wide range of lower limb
procedures to reinforce and enhance the company’s goal
of developing the most attractive, anatomically-focused product
portfolio available for use by foot and ankle surgeons. These
systems reinforce SBi’s commitment to work with key
opinion leaders to provide product solutions that serve the
full range of clinical needs of surgeons and their patients.”
* Source: Ortho Fact book – Knowledge Enterprise, 2005
Guido LaPorta, DPM, FACFAS provides consulting services to
SBi.
About
Small Bone Innovations, Inc.
Small Bone Innovations, Inc. (SBi), founded in 2004 by Viscogliosi
Brothers, LLC, (VB), the New York-based merchant banking firm
specializing in musculoskeletal/orthopedics, is the first
company to focus purely on small bones & joints. By integrating
established companies and professionals in the field, SBi
offers a broad, clinically proven portfolio of products and
technologies to treat trauma and diseases in small bones &
joints. SBi has facilities in New York; Morrisville, PA; Bourg-en-Bresse,
France; Donaueschingen, Germany and Kuala Lumpur, Malaysia.
For more information, please visit: www.totalsmallbone.com
Forward-looking
statements
This news release contains forward-looking statements as defined
in the U.S. Private Securities Litigation Reform Act of 1995.
Readers are cautioned not to place undue reliance on these
forward-looking statements. Actual results may differ materially
from those indicated by these forward-looking statements as
a result of risks and uncertainties impacting SBi’s
business including increased competition; the ability of SBi
to expand its operations and to attract and retain qualified
professionals; technological obsolescence; general economic
conditions; and other risks. |